论文部分内容阅读
目的研究金纳多注射液在缺血性脑卒中患者中的临床疗效。方法缺血性脑卒中患者79例,按随机数字表法分为将其分为对照组39例,给予常规治疗方法;观察组40例,给予常规治疗方法加用金纳多注射液。比较两组患者总体疗效及神经功能缺损评分(NDS)、脑卒中严重程度评分(FMA)变化情况。结果观察组总有效率为87.5%,高于对照组的69.2%,差异有统计学意义(P<0.05)。两组治疗后与治疗前比较,NDS评分显著下降、FMA评分显著升高,差异均有统计学意义(P<0.05)。治疗后观察组与对照组比较,NDS评分差异有统计学意义(P<0.05)。结论采用金纳多注射液治疗缺血性脑卒中,有效提高临床总有效率,对于患者神经功能缺损和脑卒中严重程度具有显著改善效果。
Objective To study the clinical efficacy of Ginaton injection in patients with ischemic stroke. Methods A total of 79 patients with ischemic stroke were divided into control group (n = 39) according to random number table method and received routine treatment. The observation group (n = 40) received routine treatment with Ginaton injection. The curative effect, NDS score and severity of stroke score (FMA) were compared between the two groups. Results The total effective rate in observation group was 87.5%, which was higher than that in control group (69.2%), the difference was statistically significant (P <0.05). After treatment, the scores of NDS and FMA in treatment group were significantly lower than those before treatment (P <0.05). After treatment, the NDS score of the observation group and the control group were significantly different (P <0.05). Conclusions The use of Ginaton injection in the treatment of ischemic stroke can effectively improve the total effective rate of the patients and significantly improve the neurological deficit and the severity of stroke.